Low FOXA1 expression predicts good response to neo-adjuvant chemotherapy resulting in good outcomes for luminal HER2-negative breast cancer cases.
Br J Cancer
; 112(2): 345-51, 2015 Jan 20.
Article
in En
| MEDLINE
| ID: mdl-25422910
Full text:
1
Database:
MEDLINE
Main subject:
Breast Neoplasms
/
Antineoplastic Combined Chemotherapy Protocols
/
Gene Expression
/
Carcinoma, Ductal, Breast
/
Hepatocyte Nuclear Factor 3-alpha
Type of study:
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Language:
En
Journal:
Br J Cancer
Year:
2015
Type:
Article
Affiliation country:
Japan